Dogwood Therapeutics, Inc DWTX
1.36
(0.07)
(4.90%)
as of 25 Sep
- Market cap
- $48.6M
- P/E
- 0.0×
Follow DWTX
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
— | 0.03 | 0.19 | 20.55 | 12.37 | 8.02 | 11.62 | 5.21 | 2.76 |
Net Debt/EBITDA |
— | 0.02 | (1.57) | 2.99 | 0.90 | 0.57 | 0.61 | (0.04) | 0.23 |
Debt/Assets |
0.00% | 0.00% | 1,151.47% | 0.00% | 0.00% | 0.00% | 0.00% | 16.31% | 0.00% |
Debt/Equity |
— | 0.00 | (0.72) | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.60 | 0.85 | 0.38 | 0.98 | 0.94 | 0.92 | 0.68 | 0.44 |
Capex/Depreciation |
— | — | 0.00 | 0.00 | — | — | — | 0.00 | 0.00 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 12.90% | 24.54% | (83.03%) | (71.83%) | (112.22%) | (95.14%) | 407.25% | (109.66%) | |
| — | (6,414.57%) | (1,295.76%) | (65.10%) | (67.56%) | (101.45%) | (84.50%) | (26.13%) | (38.50%) | |
ROIC |
— | 0.00% | 0.00% | (4,297.85%) | (1,983.28%) | (2,604.76%) | (694.76%) | (11.79%) | (25.57%) |
Return on Tangible Assets |
— | 164.62% | 189.55% | (34.56%) | (110.06%) | (167.17%) | (139.12%) | (96.11%) | (659.52%) |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.82 | 0.90 |
Share Based Compensation of Revenue |
— | — | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
— | (0.15) | (10.82) | (19.76) | (47.09) | (25.90) | (6.49) | (8.55) | (3.14) |
Cash per Share |
— | 0.00 | 1.60 | 151.17 | 42.04 | 15.88 | 4.42 | 14.44 | 1.31 |
Shareholders Equity per Share |
— | (1.83) | (25.96) | 151.91 | 43.52 | 16.55 | 5.07 | 62.53 | 15.05 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (1.83) | (25.96) | 151.91 | 43.52 | 16.55 | 5.07 | 62.53 | 15.05 |
Free Cash Flow |
— | (1.27) | (2.09) | (3.90) | (15.69) | (11.47) | (4.87) | (8.79) | (15.62) |
Working Capital |
— | (1.28) | (1.30) | 29.94 | 14.50 | 7.33 | 3.81 | 13.37 | 5.37 |
Net Current Asset Value |
— | (1.28) | (5.02) | 29.94 | 14.50 | 7.33 | 3.81 | (13.48) | (6.84) |
| Other line items | |||||||||
Quick Ratio |
— | 0.02 | 0.19 | 19.45 | 10.98 | 6.74 | 9.25 | 4.67 | 2.13 |
Depreciation/Fixed assets |
— | — | 0.00 | 0.00 | — | — | — | 4.20 | 4.25 |
Cash ROIC |
— | 8.37% | 195.42% | (6.52%) | (55.03%) | (79.87%) | (68.37%) | (9.32%) | (19.20%) |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (0.15) | (10.82) | (19.76) | (47.09) | (25.90) | (6.49) | (8.55) | (3.14) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
— | 0.09 | 0.09 | 0.20 | 0.36 | 0.46 | 0.34 | 0.67 | 1.00 |
Average Assets |
— | 0.03 | 0.19 | 15.89 | 23.62 | 12.07 | 6.27 | 49.24 | 92.24 |
Average Common Equity |
— | (16.38) | (10.08) | 12.46 | 22.22 | 10.91 | 5.57 | (3.16) | 32.39 |
Net Profit Margin |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates